Photo from wikipedia
Few studies examined the outcome of patients with hepatitis C virus (HCV)‐related cirrhosis who developed hepatocellular carcinoma (HCC). The relative weight as determinant of death for cancer vs end‐stage liver… Click to show full abstract
Few studies examined the outcome of patients with hepatitis C virus (HCV)‐related cirrhosis who developed hepatocellular carcinoma (HCC). The relative weight as determinant of death for cancer vs end‐stage liver disease (ESLD) and the benefit of HCV eradication remain undefined. This multicentre, retrospective analysis evaluates overall survival (OS), rate of decompensation and tumour recurrence in compensated HCC patients treated with interferon (IFN) according to HCV status since HCC diagnosis.
Keywords:
hepatocellular carcinoma;
related cirrhosis;
improved survival;
hepatitis virus
Journal Title: Liver International
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Liver International
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!